The Medicines Company Acquires Rempex Pharmaceuticals for $140M Plus Milestone Payments

The Medicines Company (NASDAQ: MDCO ) today announced that it has acquired Rempex Pharmaceuticals, Inc., a company with multiple potential new therapies focused on multi-drug resistant gram-negative bacteria. Clive Meanwell, MD, PhD, Chairman and Chief Executive Officer of The Medicines Company, said, "Acute and intensive care hospitals around the